| ID | Peptide Seq | Site Residue | Position in Peptide | Position in Protein |
|---|---|---|---|---|
| 10000982 | ENLPVSSDGNLPQQAASAPSR | S | 17 | 339 |
| 10002574 | 339 | |||
| 10003053 | 328 | |||
| 10011429 | TLLPPFRKPQTVAASSIYSMYTQQQAPGKNF | S | 608 | |
| 10011430 | NLPVSSDGNLPQQAASAPSRVAAVGPYIQSS | S | 339 | |
| 10013025 | MDLTLAELQEMASR | S | 136 | |
| 10015264 | ENLPVSSDGNLPQQAASAPSR | S | 17 | 339 |
| 10023622 | ENLPVSSDGNLPQQAASAPSR | S | 17 | 339 |
| 10025951 | ENLPVSSDGNLPQQAASAPSR | S | 20 | 342 |
| 10026491 | ENLPVSSDGNLPQQAASAPSR | S | 6 | 328 |
| 10026767 | ENLPVSSDGNLPQQAASAPSR | S | 17 | 339 |
| 10027016 | ENLPVSSDGNLPQQAASAPSR | S | 7 | 329 |
| 10029686 | ENLPVSSDGNLPQQAASAPSR | S | 6 | 328 |
| 10030211 | S | 328 | ||
| 10032418 | ENLPVSSDGNLPQQAASAPSR | S | 339 | |
| 10033894 | ENLPVSSDGNLPQQAASAPSR | S | 17 | 339 |
| 10036528 | ENLPVSSDGNLPQQAASAPSR | S | 329 | |
| 10037201 | ENLPVSSDGNLPQQAASAPSR | 339 | ||
| 10037525 | ENLPVSSDGNLPQQAASAPSR | 329 | ||
| 10037526 | ENLPVSSDGNLPQQAASAPSR | 339 |
| ID | Method | Analytical Throughput | Ambiguity | Species | Sample Type | Condition | log2Ratio | P Value | Data Source PMID | Comments |
|---|---|---|---|---|---|---|---|---|---|---|
| 10000982 | MS | HTP | unambiguous | human | HeLa cells | 20 uM GalNAz/200 uM GalNAz | None | 30059200 | ||
| 10002574 | MS | HTP | unambiguous | human | HeLa cells | Mitotic exit/Early mitosis | None | 34161081 | The p value was -log10p in original paper. | |
| 10003053 | MS | HTP | unambiguous | human | colorectal cancer (CRC) cell lines | SW620 cells/SW480 cells | None | 0.00272166 | 35254053 | |
| 10011429 | MS | HTP | unambiguous | human | HeLa cells | None | 30059200 | |||
| 10011430 | MS | HTP | unambiguous | human | HeLa cells | None | 30059200 | |||
| 10013025 | MS | HTP | unambiguous | human | HeLa cells | None | 30379171 | |||
| 10015264 | MS | HTP | unambiguous | human | HeLa cells | None | 31492838 | |||
| 10023622 | MS | HTP | unambiguous | human | THP1 cells | None | 32938750 | |||
| 10025951 | MS | HTP | unambiguous | human | HeLa cells | None | 35254053 | |||
| 10026491 | MS | HTP | unambiguous | human | HeLa cells | None | 35254053 | |||
| 10026767 | MS | HTP | unambiguous | human | HeLa cells | None | 35254053 | |||
| 10027016 | MS | HTP | unambiguous | human | HeLa cells | None | 35254053 | |||
| 10029686 | MS | HTP | unambiguous | human | SW620 cells | None | 35254053 | |||
| 10030211 | MS | HTP | unambiguous | human | SW480 cells, SW620 cells | SW620/SW480 | None | 0.00272166 | 35254053 | |
| 10032418 | MS | HTP | unambiguous | human | MCF-7 cells | None | 35513511 | |||
| 10033894 | MS | HTP | unambiguous | human | HEK 293T cells | glucose-deprived/glucose-sufficient | None | 37541260 | ||
| 10036528 | MS | HTP | unambiguous | human | HEK 293T cells | None | 30620550 | |||
| 10037201 | MS | HTP | unambiguous | human | HEK 293T cells | TMG/control | None | 30620550 | Peptide quantification value was applied to each modification site | |
| 10037525 | MS | HTP | unambiguous | human | HepG2 cells | orafenib sensitive/resistant | None | 30620550 | Peptide quantification value was applied to each modification site | |
| 10037526 | MS | HTP | unambiguous | human | HepG2 cells | orafenib sensitive/resistant | None | 30620550 | Peptide quantification value was applied to each modification site |
| ID | Peptide Seq | Site Residue | Position in Peptide | Position in Protein | Method | Analytical Throughput | Ambiguity | Species | Sample Type | Data Source PMID | Comments |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10000982 | ENLPVSSDGNLPQQAASAPSR | S | 17 | 339 | MS | HTP | unambiguous | human | HeLa cells | 30059200 | |
| 10002574 | 339 | MS | HTP | unambiguous | human | HeLa cells | 34161081 | The p value was -log10p in original paper. | |||
| 10003053 | 328 | MS | HTP | unambiguous | human | colorectal cancer (CRC) cell lines | 35254053 | ||||
| 10011429 | TLLPPFRKPQTVAASSIYSMYTQQQAPGKNF | S | 608 | MS | HTP | unambiguous | human | HeLa cells | 30059200 | ||
| 10011430 | NLPVSSDGNLPQQAASAPSRVAAVGPYIQSS | S | 339 | MS | HTP | unambiguous | human | HeLa cells | 30059200 | ||
| 10013025 | MDLTLAELQEMASR | S | 136 | MS | HTP | unambiguous | human | HeLa cells | 30379171 | ||
| 10015264 | ENLPVSSDGNLPQQAASAPSR | S | 17 | 339 | MS | HTP | unambiguous | human | HeLa cells | 31492838 | |
| 10023622 | ENLPVSSDGNLPQQAASAPSR | S | 17 | 339 | MS | HTP | unambiguous | human | THP1 cells | 32938750 | |
| 10025951 | ENLPVSSDGNLPQQAASAPSR | S | 20 | 342 | MS | HTP | unambiguous | human | HeLa cells | 35254053 | |
| 10026491 | ENLPVSSDGNLPQQAASAPSR | S | 6 | 328 | MS | HTP | unambiguous | human | HeLa cells | 35254053 | |
| 10026767 | ENLPVSSDGNLPQQAASAPSR | S | 17 | 339 | MS | HTP | unambiguous | human | HeLa cells | 35254053 | |
| 10027016 | ENLPVSSDGNLPQQAASAPSR | S | 7 | 329 | MS | HTP | unambiguous | human | HeLa cells | 35254053 | |
| 10029686 | ENLPVSSDGNLPQQAASAPSR | S | 6 | 328 | MS | HTP | unambiguous | human | SW620 cells | 35254053 | |
| 10030211 | S | 328 | MS | HTP | unambiguous | human | SW480 cells, SW620 cells | 35254053 | |||
| 10032418 | ENLPVSSDGNLPQQAASAPSR | S | 339 | MS | HTP | unambiguous | human | MCF-7 cells | 35513511 | ||
| 10033894 | ENLPVSSDGNLPQQAASAPSR | S | 17 | 339 | MS | HTP | unambiguous | human | HEK 293T cells | 37541260 | |
| 10036528 | ENLPVSSDGNLPQQAASAPSR | S | 329 | MS | HTP | unambiguous | human | HEK 293T cells | 30620550 | ||
| 10037201 | ENLPVSSDGNLPQQAASAPSR | 339 | MS | HTP | unambiguous | human | HEK 293T cells | 30620550 | Peptide quantification value was applied to each modification site | ||
| 10037525 | ENLPVSSDGNLPQQAASAPSR | 329 | MS | HTP | unambiguous | human | HepG2 cells | 30620550 | Peptide quantification value was applied to each modification site | ||
| 10037526 | ENLPVSSDGNLPQQAASAPSR | 339 | MS | HTP | unambiguous | human | HepG2 cells | 30620550 | Peptide quantification value was applied to each modification site |